INO

Inovio Pharmaceuticals
$0.97
−$0.01 (−0.52%)Jul 27, 2026
0.5PoorMoatMint rating

MoatMint rates Inovio Pharmaceuticals (INO) 0.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.3 out of 10.

Key metrics

The numbers that frame INO today
Market cap
$79.39M
P/E (TTM)
-0.9
EV / FCF
-0.7
ROIC
2,404%
Div yield
0%
Debt / equity
1.4
52wk Low
$0.96
52wk High
$2.98

INO stock rating

How INO scores on quality, value, growth, momentum and financial health
0.5out of 10
Low overallNeutral business, expensive priceTop 95% of ~5,000 US stocks
QualityPoor1.3/10
GrowthFair3.9/10
MomentumFair2.0/10
ValuePoor0.3/10
Financial HealthPoor1.5/10

Growth

Revenue and earnings trend for INO
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about INO
Is Inovio Pharmaceuticals a good buy?
No. Inovio Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Inovio Pharmaceuticals is selling at a very high price.
What is the market capitalization of INO?
Inovio Pharmaceuticals's market capitalization is $79.39M.
What is the P/E ratio for INO stock?
Inovio Pharmaceuticals's current P/E ratio is -0.9.
What is the 52-week high for INO stock?
The 52-week high for Inovio Pharmaceuticals is $2.98. The current close of $0.97 is 67.6% below that high.
What is the 52-week low for INO stock?
The 52-week low for Inovio Pharmaceuticals is $0.96. The current close of $0.97 is 0.4% above that low.
Does INO stock pay dividends?
Inovio Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for INO?
Inovio Pharmaceuticals's Debt / Equity ratio is 1.43.